- Home
- CGEM vs MLAB Comparison
CGEM vs MLAB Comparison
Compare CGEM & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- MLAB
- Stock Information
- Founded
- CGEM 2016
- MLAB 1982
- Country
- CGEM United States
- MLAB United States
- Employees
- CGEM N/A
- MLAB N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- MLAB Industrial Machinery/Components
- Sector
- CGEM Health Care
- MLAB Industrials
- Exchange
- CGEM Nasdaq
- MLAB Nasdaq
- Market Cap
- CGEM 730.2M
- MLAB 692.9M
- IPO Year
- CGEM 2021
- MLAB N/A
- Fundamental
- Price
- CGEM $10.55
- MLAB $140.47
- Analyst Decision
- CGEM Strong Buy
- MLAB Hold
- Analyst Count
- CGEM 7
- MLAB 2
- Target Price
- CGEM $31.67
- MLAB $140.00
- AVG Volume (30 Days)
- CGEM 551.6K
- MLAB 29.0K
- Earning Date
- CGEM 03-13-2025
- MLAB 02-04-2025
- Dividend Yield
- CGEM N/A
- MLAB 0.46%
- EPS Growth
- CGEM N/A
- MLAB N/A
- EPS
- CGEM N/A
- MLAB N/A
- Revenue
- CGEM N/A
- MLAB $228,380,000.00
- Revenue This Year
- CGEM N/A
- MLAB $11.39
- Revenue Next Year
- CGEM N/A
- MLAB $5.62
- P/E Ratio
- CGEM N/A
- MLAB N/A
- Revenue Growth
- CGEM N/A
- MLAB 6.88
- 52 Week Low
- CGEM $9.50
- MLAB $83.68
- 52 Week High
- CGEM $30.19
- MLAB $149.50
- Technical
- Relative Strength Index (RSI)
- CGEM 38.45
- MLAB 56.44
- Support Level
- CGEM $10.14
- MLAB $138.64
- Resistance Level
- CGEM $11.31
- MLAB $148.00
- Average True Range (ATR)
- CGEM 0.64
- MLAB 6.42
- MACD
- CGEM 0.01
- MLAB 0.13
- Stochastic Oscillator
- CGEM 30.11
- MLAB 62.06
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.